Piramal Pharma Solutions Opens Oral Solid Dosage Drug Product Facility

Piramal Pharma Solutions, a contract development and manufacturing organization (CDMO) headquartered in India, held a grand opening event at their recently acquired solid oral dosage drug product manufacturing facility located in Sellersville, PA. The company acquired the site in June 2020 from G&W Laboratories. This site gives Piramal capabilities for product and process development, manufacturing, and packaging of solid oral dosage forms, liquids, creams, and ointments in North America.

“We are rapidly growing and we take pride in the fact that we let our customers guide how and where we grow. The Sellersville facility is a great example of this. It was acquired because it addresses a market need for solid oral dosage form development and manufacturing in the United States. It also gives us new capabilities in liquids, creams, and ointments,” said Peter DeYoung, Piramal Pharma Solutions CEO, in the Sept. 21, 2020 press release.

“Bringing the Sellersville site into the family significantly helps us accomplish our goal of getting medicines to patients. This is the thirteenth facility in our global network and our first solid dose facility in North America, giving us critical mass that matches local market need,” said John Fowler, chief operating officer, Piramal Pharma Solutions, in the press release.